Innate Pharma Overview

Innate Pharma Operating Income

Operating Income for IPHA.

Quarterly Operating Income

$-31377014.00

↑ 24.21% YoY

As of Dec 31, 2025

Annual Operating Income (TTM)

$-95222514.00

↑ 128.35% YoY

Trailing 12 months ending Dec 31, 2025

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin